Industry Impact of Supreme Court Gene-Patent Ruling

Industry Impact of Supreme Court Gene-Patent Ruling Play

June 13 (Bloomberg) -- The U.S. Supreme Court restricted the ability of companies to patent human genetic sequences, issuing a mixed ruling in a case that raised questions about thousands of biotechnology, agricultural and drug patents. Greg Stohr reports on Bloomberg Television's "Bottom Line." (Source: Bloomberg)

  • On Air Now

    Titans at the Table: Jonathan Tisch Watch Now

  • Next

    Inside Johnson & Johnson

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus